• Profile
Close

Genetic testing in a population-based sample of breast and ovarian cancer survivors from the REACH randomized trial: Cost barriers and moderators of counseling mode

Cancer Epidemiology, Biomarkers & Prevention Oct 06, 2017

Steffen LE, et al. - In this study, predictors of BRCA1/2 testing were assessed among breast and ovarian cancer survivors who received genetic counseling as part of a randomized trial and moderators of counseling mode on testing uptake were determined. Researchers recognized cost concerns as a strong determinant of testing. Pre-counseling distress and risk perceptions seemed to influence the differences in testing uptake by counseling mode. In population-based samples of at risk cancer survivors, cost concerns could contribute to low testing. They recommended considering pre-counseling psychosocial characteristics when offering in-person vs. telephone counseling.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay